Variant Bio
Variant Bio is leveraging the power of human genetic diversity to discover new therapeutics.
About Variant Bio
Variant Bio is leveraging the power of human genetic diversity to discover new therapeutics. The company's focus is to identify individuals and populations around the world who are extreme outliers for traits of medical relevance and to use innovative sequencing and analytic approaches to identify genes and pathways linked to these traits. Variant Bio was founded in 2018 and headquartered in Seattle, Washington.
Company Facts
- Headquarters
- Seattle
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00011_00050
- Funding Stage
- early_stage_venture
- Total Funding
- $129,700,000
- Last Funding Type
- series_b
- Last Funding Date
- 2021-11-09
- Website
- variantbio.com
Industries & Categories
Biotechnology, Genetics, Medical, Therapeutics
Social Links
Canonical: https://fsome.com/organization/variant-bio-11590 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.